Sweden

Legal status	VERY PERMISSIVE
Key organization	Swedish Research Council
Policy	hESC research is allowed if IVF embryos of up to 14 days post-fertilisation are used or after SCNT. Therapeutic cloning is allowed if hereditary genetic traits remain unchanged. Reproductive cloning is banned.
Regulations	1. Legal Regulation of Stem Cell Research 2002:119: http://www.regeringen.se/sb/d/108/a/2717 2. Regulations and Guidelines for the Use of Tissues and Cells in Healthcare and Clinical Research - SOSFS 2009:32: http://www.socialstyrelsen.se/sosfs/2009-32
Legislation	Act on Genetic Integrity (2006:351)
Legislation Link	http://www.notisum.se/rnp/sls/lag/20060351.htm
Embryonic stem cell research policy	hESC reseach is allowed with the approval by a Regional Research Ethics Board.
Research with embryo	Research with embryo is allowed. In fact, the creation of embryo for research is also allowed with the approval by a Regional Research Ethics Board.
Embryo donation and cryopreservation	Embryo donation and cryopreservation is allowed in Sweden.
Somatic cell nuclear transfer	SCNT is allowed for research purposes.
Privacy and data protection	Patient Data Act: SFS 2008:355 (Swedish): http://www.notisum.se/rnp/sls/lag/20080355.htm

Projects

• A Functional, Mature In vivo Human Ventricular Muscle Patch for Cardiomyopathy
• A PRECISION CELL REPLACEMENT STRATEGY FOR PARKINSON’S DISEASE
• Epigenetic drug action
• Epigenetic regulation of early human development
• Genetic variation exposes regulators of blood cell formation in vivo in humans
• Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype?
• Patient-specific treatment for Parkinson’s disease using reprogrammed skin cells
• Paving the way for High-throughput Organoid ENgineering using Integrated acoustiX
• Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design
• Safeguarding Female Fertility -development of human-relevant in vitro tools for reproductive toxicity
• Smedler lab
• STEM-PD trial: A multicentre, single arm, first in human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell derived dopaminergic cells for Parkinson’s disease (STEM-PD product)
• Unveiling the functional outcome of single nucleotide polymorphisms and variants in oligodendroglia in multiple sclerosis

Provider

• (WITHDRAWN) Cellartis AB
• (WITHDRAWN) Cellartis AB
• (WITHDRAWN) Karolinska Institutet
• (WITHDRAWN) The Sahlgrenska Academy at University of Gothenburg
• AstraZeneca AB
• Karolinska Institutet
• Karolinska Institutet - Department of Neuroscience
• Karolinska Institutet - Pan-Hammarström laboratory
• Karolinska Institutet - Stem Cell & Organoid Laboratory
• Karolinska Institutet - Stem Cell Laboratory
• Linköping University
• Lund University
• Sahlgrenska University Hospital
• Skåne University Hospital
• Takara Bio Europe AB (former Cellartis)
• Takara Bio Europe AB (former Cellartis) - Human ES cell line derivation
• The Sahlgrenska Academy at University of Gothenburg
• University of Lund
• Uppsala University
• Uppsala University - Department of Immunology, Genetics and Pathology
• Uppsala University - Department of Medical Cell Biology

hESC Cell lines

• CEBe034-A-1
• CEBe001-A
• CEBe002-A
• CEBe006-A
• CEBe007-A
• CEBe008-A
• CEBe009-A
• CEBe010-A
• CEBe011-A
• CEBe012-A
• CEBe013-A
• CEBe014-A
• CEBe015-A
• CEBe016-A
• CEBe017-A
• CEBe018-A
• CEBe019-A
• CEBe020-A
• CEBe021-A
• CEBe022-A
• CEBe023-A
• CEBe024-A
• CEBe025-A
• CEBe026-A
• CEBe027-A
• CEBe028-A
• CEBe029-A
• CEBe030-A
• CEBe031-A
• CEBe032-A
• KIe001-A
• KIe002-A
• KIe003-A
• KIe004-A
• KIe005-A
• KIe006-A
• KIe007-A
• KIe008-A
• KIe009-A
• KIe010-A
• KIe011-A
• KIe012-A
• KIe013-A
• KIe014-A
• KIe015-A
• KIe016-A
• KIe017-A
• KIe018-A
• KIe019-A
• KIe020-A
• KIe021-A
• KIe022-A
• KIe023-A
• KIe024-A
• KIe025-A
• KIe026-A
• KIe027-A
• KIe028-A
• KIe029-A
• CEBe033-A
• CEBe034-A
• CEBe035-A
• KIe030-A
• KIe024-A-1
• KIe024-A-2
• KIe024-A-3
• KIe024-A-4
• KIe031-A
• KIe001-A-1
• KIe004-A-1
• KIe006-A-1
• KIe007-A-1
• KIe008-A-1
• KIe009-A-1
• KIe010-A-1
• KIe011-A-1
• KIe012-A-1
• KIe013-A-1
• KIe014-A-1
• KIe015-A-1
• KIe016-A-1
• KIe017-A-1
• KIe018-A-1
• KIe019-A-1
• KIe020-A-1
• KIe021-A-1
• KIe022-A-1
• KIe032-A
• KIe033-A
• CEBe002-A-1
• CEBe002-A-2
• CEBe002-A-3
• KIe034-A
• KIe035-A
• KIe036-A
• KIe037-A
• KIe038-A
• KIe039-A
• KIe040-A
• KIe041-A
• KIe042-A
• KIe043-A
• KIe044-A
• KIe045-A
• KIe046-A
• KIe047-A
• KIe048-A
• KIe049-A
• KIe050-A
• KIe051-A
• KIe052-A
• KIe053-A
• KIe054-A
• KIe055-A
• KIe056-A
• KIe057-A
• KIe058-A
• KIe059-A
• KIe060-A
• KIe061-A
• NOVOe001-A

hiPSC Cell lines

• ULUNDi001-A
• ULUNDi002-A
• ULUNDi004-A
• ULUNDi005-A
• ULUNDi006-A
• KIi001-A
• KIi002-A
• ULUNDi007-A
• UUIGPi001-A
• UUIGPi002-A
• UUIGPi003-A
• UUIGPi004-A
• UUIGPi005-A
• UUIGPi006-A
• UUIGPi007-A
• UUIGPi008-A
• PHAi001-A
• PHAi002-A
• PHAi003-A
• PHAi001-B
• PHAi002-B
• PHAi003-B
• KICRi001-A
• ULUNDi008-A
• UUIGPi009-A
• UUIGPi010-A
• UUIGPi011-A
• KICRi002-A
• KICRi002-A-1
• KICRi002-A-2
• KICRi002-A-3
• KISCOi001-A
• UUMCBi001-A
• UUMCBi002-A
• UUIGPi013-A
• UUIGPi014-A
• UGOTSAi001-A
• KICRi002-A-4
• KICRi002-A-5
• UUIGPi015-A
• UGOTSAi002-B
• UGOTSAi003-A
• UGOTSAi003-B
• UGOTSAi004-A
• UGOTSAi004-B
• UGOTSAi005-A
• UGOTSAi005-B
• UGOTSAi006-A
• STBCi322-A-1
• STBCi322-A-2
• STBCi322-A-3
• STBCi014-B-1
• STBCi322-A-4
• STBCi322-A-5
• STBCi322-A-6
• STBCi028-A-1
• STBCi017-A-1
• STBCi322-A-7
• SUHi001-A
• SUHi002-A
• SUHi003-A
• SUHi004-A
• SUHi005-A
• SUHi006-A
• UUIGPi016-A
• UUIGPi017-A
• UUIGPi018-A
• SUHi007-A
• SUHi008-A
• SUHi009-A
• SUHi010-A
• SUHi011-A
• SUHi012-A
• SUHi013-A
• SUHi014-A
• SUHi015-A
• SUHi016-A
• SUHi017-A
• SUHi018-A
• SUHi019-A
• SUHi020-A
• SUHi021-A
• SUHi022-A
• SUHi023-A
• SUHi024-A
• KIi003-A